WallStSmart

Diversified Healthcare Trust (DHC)vsEquinix Inc (EQIX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Equinix Inc generates 528% more annual revenue ($9.53B vs $1.52B). EQIX leads profitability with a 14.9% profit margin vs -21.1%. DHC appears more attractively valued with a PEG of 1.89. EQIX earns a higher WallStSmart Score of 54/100 (C-).

DHC

Hold

39

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.3Quality: 5.5
Piotroski: 5/9Altman Z: -0.24

EQIX

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 2.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.55
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHCUndervalued (+89.4%)

Margin of Safety

+89.4%

Fair Value

$59.41

Current Price

$8.89

$50.52 discount

UndervaluedFair: $59.41Overvalued
EQIXSignificantly Overvalued (-86.5%)

Margin of Safety

-86.5%

Fair Value

$561.23

Current Price

$1008.02

$446.79 premium

UndervaluedFair: $561.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

EQIX3 strengths · Avg: 8.3/10
Market CapQuality
$101.46B9/10

Large-cap with strong market position

Operating MarginProfitability
24.3%8/10

Strong operational efficiency at 24.3%

EPS GrowthGrowth
20.0%8/10

Earnings expanding 20.0% YoY

Areas to Watch

DHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Debt/EquityHealth
1.493/10

Elevated debt levels

Return on EquityProfitability
-19.8%2/10

ROE of -19.8% — below average capital efficiency

Revenue GrowthGrowth
-5.3%2/10

Revenue declined 5.3%

EQIX4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.633/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.352/10

Expensive relative to growth rate

P/E RatioValuation
71.0x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bull Case : EQIX

The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth. Revenue growth of 12.1% demonstrates continued momentum.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Debt/Equity, Return on Equity.

Bear Case : EQIX

The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 71.0x leaves little room for execution misses. Debt-to-equity of 1.63 is elevated, increasing financial risk.

Key Dynamics to Monitor

DHC profiles as a turnaround stock while EQIX is a value play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.27 — expect wider price swings.

EQIX is growing revenue faster at 12.1% — sustainability is the question.

DHC generates stronger free cash flow (-27M), providing more financial flexibility.

Bottom Line

EQIX scores higher overall (54/100 vs 39/100) and 12.1% revenue growth. DHC offers better value entry with a 89.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Equinix Inc

REAL ESTATE · REIT - SPECIALTY · USA

Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.

Visit Website →

Want to dig deeper into these stocks?